N
Norman R. Farnsworth
Researcher at University of Illinois at Chicago
Publications - 302
Citations - 22801
Norman R. Farnsworth is an academic researcher from University of Illinois at Chicago. The author has contributed to research in topics: Black cohosh & Epidermoid carcinoma. The author has an hindex of 62, co-authored 302 publications receiving 21485 citations. Previous affiliations of Norman R. Farnsworth include Ohio State University & Mahidol University.
Papers
More filters
Journal ArticleDOI
Potential consequence of plant extinction in the United States on the current and future availability of prescription drugs
TL;DR: This paper attempts to answer the question: What is the dollar value that can be placed on a single plant species now growing in the United States, should it become extinct?
Journal ArticleDOI
Xanthohumol isolated from Humulus lupulus Inhibits menadione-induced DNA damage through induction of quinone reductase.
Birgit M. Dietz,Young Hwa Kang,Guowen Liu,Aimee L. Eggler,Ping Yao,Lucas R. Chadwick,Guido F. Pauli,Norman R. Farnsworth,Andrew D. Mesecar,Richard B. van Breemen,Judy L. Bolton +10 more
TL;DR: XH and hops dietary supplements might function as chemopreventive agents, through induction of detoxification enzymes such as QR, using LC-MS-MS, which suggests that XH induces QR by covalently modifying the Keap1 protein.
Book ChapterDOI
The Role of Ethnopharmacology in Drug Development
TL;DR: In this article, the authors present a pre-screen to select plants for experimental pharmacological studies, using ethnopharmacology, folk medicine, and traditional medicine data from various indigenous cultures.
Journal ArticleDOI
Potential sweetening agents of plant origin. iii. organoleptic evaluation of stevia leaf herbarium samples for sweetness
TL;DR: Fragments of a 62-year-old leaf of S. rebaudiana exhibited a potent and prolonged sensation of sweetness, thereby indicating the stability of its sweet ent-kaurene glycoside constituents to drying, preservation, mounting and storage.
Journal ArticleDOI
Silvestrol and episilvestrol, potential anticancer rocaglate derivatives from Aglaia silvestris.
Bang Yeon Hwang,Bao Ning Su,Heebyung Chai,Qiuwen Mi,Leonardus B.S. Kardono,Johar J. Afriastini,Soedarsono Riswan,Bernard D. Santarsiero,Andrew D. Mesecar,Robert A. Wild,Craig R. Fairchild,Gregory D. Vite,William C. Rose,Norman R. Farnsworth,Geoffrey A. Cordell,John M. Pezzuto,Steven M. Swanson,A. Douglas Kinghorn +17 more
TL;DR: Two cytotoxic rocaglate derivatives possessing an unusual dioxanyloxy unit, silvestrol and episilvestrol, were isolated from the fruits and twigs of Aglaia silvestris by bioassay-guided fractionation monitored with a human oral epidermoid carcinoma (KB) cell line.